Authors
Latest:
Management of Cytopenia Post CAR T-Cell TherapyThis review explores cytopenia after CAR T-cell therapy, including its risk stratification and management with growth factors, thrombopoietin-receptor agonists, and hematopoietic stem cell boosts.
Latest:
Updated ASCO-NCODA MIP Standards Emphasize Health Equity, Patient-Centered Care, and Integrated Workflows in Oral Oncolytic ManagementGurjyot K. Doshi, MD, discusses key updates to medically integrated pharmacy standards, which reflect the evolving landscape of oral oncolytic therapy.
Latest:
Help Optimize Care for Orphan, Rare Lung Diseases Amid COVID-19 PandemicThe value of a patient-first approach and telehealth for addressing the complex health coordination needs of those with these pulmonary conditions has never been more critical.
Latest:
SGO 2025: The MRI Gap and How Race and Insurance Shape Cervical Cancer Treatment TimelinesSophie Jabban discusses research presented at the SGO Annual Meeting highlighting significant disparities in MRI access for patients with cervical cancer receiving chemoradiation, with delays linked to both race and insurance status, underscoring systemic barriers that may impact timely treatment.
Latest:
Drug Sequestration in the Management of Patients with Extracorporeal Membrane Oxygenation SupportDosing recommendations for patients requiring ECMO support are unlikely to be supported by high-quality evidence, but are usually extrapolated from the physicochemical characteristics of individual drugs in conjunction with data from pharmacokinetic studies and case reports.
Latest:
Unmet Needs in Relapsed or Refractory Multiple MyelomaSarah Rockwell, PharmD, BCOP, and Ke Ning, MD, share their concluding remarks, reflecting on the current landscape and expressing their aspirations for addressing remaining unmet needs.
Latest:
Tips to Finding Balance: Being a Well-Rounded Student PharmacistFrom countless hours of studying to participating in pharmacy organizations to volunteering in the community, it’s no surprise that student pharmacists often struggle to find balance as a well-rounded student.
Latest:
Data Show Fremanezumab Converts Chronic Migraine to Episodic, Improves Quality of Life for PatientsThe authors determined that 40 patients (74.1%) converted from chronic to episodic migraine.
Latest:
Pharmacists Play a Vital Role in Providing High-Value Care to Patients With Myasthenia GravisMyasthenia gravis is a chronic autoimmune disease that causes muscle weakness and fatigue, with 4 main treatment options available.
Latest:
New Curricular Framework Aims to Prepare, Inspire the Next Generation of Community Pharmacy LeadersThe framework includes 6 domains designed to immediately empower students in community pharmacies.
Latest:
How Precision Dosing Technology Helps Prevent Adverse EventsPrecision dosing technology uses multiple patient-specific factors to individualize medication doses, helping clinicians reduce medication errors that lead to adverse events.
Latest:
New Migraine Guidelines Aim to Help Patients Beat the PainThe updated recommendations include CGRP inhibitors as a first-line treatment option for chronic and episodic migraine prevention.
Latest:
The Role of Daridorexant in the Treatment of InsomniaAlthough pharmacotherapy is considered for the treatment of insomnia, medication should not be the sole treatment for individuals diagnosed with insomnia.
Latest:
Building a Sustainable Pharmacogenomics Program: A Pharmacist’s Perspective at Ochsner HealthSerena Mitaly, PharmD, outlines how Ochsner Health is building a sustainable pharmacogenomics program by integrating clinical decision support tools into the EMR, educating providers, addressing reimbursement barriers, and expanding the role of PGx pharmacists in personalized medicine.
Latest:
Ousting the Pain: Migraine in University StudentsStudents may be hesitant to discuss migraines, which can lead to absences, difficulties in personal life, financial burdens, and poor mental health.
Latest:
Shorter Course of Treatment for CAP in Children Demonstrates SuccessPediatric guidelines suggest 10 days of therapy for community-acquired pneumonia, but recent data support shortening therapy duration.
Latest:
How Does the EUA for the COVID-19 Vaccines Work?FDA approvals of vaccines usually take 10 to 15 years, but the pandemic necessitates emergency action.
Latest:
Supporting Medication Adherence With Motivational InterviewingMotivational Interviewing is a collaborative conversation style that can empower patients to stay the course and achieve better outcomes.
Latest:
Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology PatientsThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Pharmacy Schools Can Break Down Barriers Between Pharmacists, Deaf CommunityMost pharmacists and technicians are unaware of resources that aid in communication.
Latest:
Oncology Pharmacists Bring Value and Contribute to Cancer CareOncology pharmacists are as diverse as the cancers they manage and have key roles in the following areas of the cancer care continuum.
Latest:
From Setbacks to Solutions: Pioneering Safe RSV Vaccines for Infants, ChildrenWith respiratory syncytial virus vaccine development for infants and children proceeding slowly, therapeutic developers have focused on passive immunity
Latest:
The Challenges in Launching Alaska's First Pharmacy SchoolA shortage of pharmacists led to a call for pharmacy education in Alaska that echoed across the state.
Latest:
Review of 3 Alternative Pathways to Access Non–FDA-Approved DrugsNon–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Latest:
The Role of Executive OrdersThese directives are typically used to shape federal agencies and manage employees in the executive branch.
Latest:
Avoiding Weight-Loss Pitfalls: How Organizations Can Strengthen Their Medication StrategyWhen used correctly, weight-loss medications, such as glucagon-like peptide-1 (GLP-1) medications, can be a tool to help reduce costs and provide clinical results.
Latest:
SGLT2 Inhibitors Are Underutilized for Inpatient Heart Failure TreatmentCardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.
Latest:
The Perfect Ingredient: Vaccine Education With Pharmacy Community Health WorkersIn Missouri, community health workers partnered with community pharmacists, CPESN, and others to develop a state-funded program to address vaccine gaps in local communities.
Latest:
How Microbial Preservation Supports Quality and Safety in Compounding PharmaciesMark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.
